World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: EUCTR
Last refreshed on: 9 October 2012
Main ID:  EUCTR2005-000869-20-EE
Date of registration: 20/06/2005
Prospective Registration: Yes
Primary sponsor: Pierre Fabre Médicament
Public title:
Scientific title: Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with suture. - Not applicable
Date of first enrolment: 18/07/2005
Target sample size: 200
Recruitment status: Not Recruiting
URL:  https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2005-000869-20
Study type:  Interventional clinical trial of medicinal product
Study design:  Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: yes Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: yes Other: no  
Phase: 
Countries of recruitment
Estonia Latvia Spain
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
- Regular user of manual toothbrush (at least once a day),
- Patient having a periodontitis,
- Patient having a periodontal surgery (flap, debridment with access flap, complicated tooth extraction, alveolectomy) with a gingival suture or several sutures on the same area, concerning one or several teeth

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion criteria:
- Smokers,
- Dental surgery such as: grafting of bone substitute material, membrane, gingivectomy, non complicated tooth extraction, scaling – root planning alone,
- any surgery that requires an antibiotic cover during or after the surgery,
- who have more than two teeth missing between the suture and an existing tooth,
- who have in the same time surgical procedures on different areas of the mouth,
- medical history of major medical, psychiatric illness or surgery which, in the judgement of the investigator, puts them ‘at risk’ or is likely to modify their handling of the study drug,
- severe acute or chronic systemic disease or disorder that should interfere with treatment or evaluation,
- any coagulation disorder,
- any buccal disorder which could interfere with the treatment or the evaluation (hyposalivation or asialia, aphtha, ulceration, lichen planus, stomatitis),
- history of alcohol or drug addiction.
- use of local antiseptics (mouthwash) within the 7 previous days,
- use of antibiotics (any route of administration) within the 7 previous days.



Age minimum:
Age maximum:
Gender:
Female: yes
Male: yes
Health Condition(s) or Problem(s) studied
Post-operative care for patients having periodontal surgery with gingival suture.
MedDRA version: 7 Level: LLT Classification code 10056984
Intervention(s)

Trade Name: ELUDRIL mouthwash
Product Name: Not applicable
Product Code: DC071BB08b
Pharmaceutical Form: Mouth wash
INN or Proposed INN: chlorhexidine digluconate
CAS Number: 18472-51-0
Current Sponsor code: NA
Concentration unit: g/l gram(s)/litre
Concentration type: equal
Concentration number: 1,1-
INN or Proposed INN: chlorobutanol
CAS Number: 6001-64-5
Current Sponsor code: NA
Other descriptive name: 2-trichloromethylisopropyl alcohol
Concentration unit: g/l gram(s)/litre
Concentration type: equal
Concentration number: 5.55-
Pharmaceutical form of the placebo: Mouth wash
Route of administration of the placebo: Oromucosal use

Primary Outcome(s)
Secondary Objective: To evaluate the patient's satisfaction and the investigator's global judgement during the post-operative period.
To evaluate the suture healing.
To document the local and general tolerance.
Main Objective: To assess the efficacy of DC071BB08b mouthwash for controlling the evolution of plaque index in peri-surgical area during the post-operative period.
Primary end point(s): Evolution of the plaque index in the peri-surgery area.
Secondary Outcome(s)
Secondary ID(s)
DC0071-BB-404-8B
2005-000869-20-ES
Not applicable
Source(s) of Monetary Support
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history